Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals

This publication has 15 references indexed in Scilit:

• The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model
  Journal of Antimicrobial Chemotherapy, 2001
• Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides
  Journal of Clinical Microbiology, 2001
• Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals
  Clinical Microbiology & Infection, 2001
• An Outbreak of Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides in a French General Hospital
  Clinical Infectious Diseases, 2000
• Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
  Journal of Antimicrobial Chemotherapy, 2000
• Molecular Typing of Methicillin-ResistantStaphylococcus aureusby Pulsed-Field Gel Electrophoresis: Comparison of Results Obtained in a Multilaboratory Effort Using Identical Protocols and MRSA Strains
  Microbial Drug Resistance, 2000
• The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
  The American Journal of Medicine, 1998
• First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
  The Lancet, 1998
• The Progressive Intercontinental Spread of Methicillin-Resistant Staphylococcus aureus
  Clinical Infectious Diseases, 1997
• Decreased Teicoplanin Susceptibility of Methicillin-Resistant Strains of Staphylococcus aureus
  The Journal of Infectious Diseases, 1995